Frankfurt - Delayed Quote EUR

Precigen, Inc. (I5X.F)

Compare
1.6450
+0.0720
+(4.58%)
At close: March 3 at 4:22:34 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,963
6,225
26,909
14,267
103,178
Cost of Revenue
4,456
6,119
6,339
5,745
55,513
Gross Profit
-493
106
20,570
8,522
47,665
Operating Expense
94,864
89,029
95,176
99,927
133,348
Operating Income
-95,357
-88,923
-74,606
-91,405
-85,683
Net Non Operating Interest Income Expense
2,118
2,769
-6,641
-18,584
-15,949
Other Income Expense
-48,363
-10,208
1,281
-978
-2,223
Pretax Income
-141,602
-96,362
-79,966
-110,967
-103,855
Tax Provision
-2,038
-458
-189
-160
-82
Net Income Common Stockholders
-139,564
-95,904
28,317
-92,166
-170,521
Diluted NI Available to Com Stockholders
-139,564
-95,904
28,317
-92,166
-170,521
Basic EPS
-0.54
-0.39
0.14
-0.47
-1.02
Diluted EPS
-0.54
-0.39
0.14
-0.47
-1.02
Basic Average Shares
256,670.8560
244,536.2210
200,360.8210
197,759.9000
167,065.5390
Diluted Average Shares
256,670.8560
244,536.2210
200,360.8210
197,759.9000
167,065.5390
Total Operating Income as Reported
-140,737
-99,758
-75,726
-91,948
-86,603
Total Expenses
99,320
95,148
101,515
105,672
188,861
Net Income from Continuing & Discontinued Operation
-139,564
-95,904
28,317
-92,166
-170,521
Normalized Income
-94,837.1295
-85,120.4978
-78,659.6471
-110,264.7829
-102,853.7264
Interest Income
2,131
3,237
133
171
2,451
Interest Expense
13
468
6,774
18,755
18,400
Net Interest Income
2,118
2,769
-6,641
-18,584
-15,949
EBIT
-141,589
-95,894
-73,192
-92,212
-85,455
EBITDA
-136,110
-89,226
-62,427
-78,451
-67,939
Reconciled Cost of Revenue
4,456
6,119
6,339
5,745
55,513
Reconciled Depreciation
5,479
6,668
10,765
13,761
17,516
Net Income from Continuing Operation Net Minority Interest
-139,564
-95,904
-79,777
-110,807
-103,773
Total Unusual Items Excluding Goodwill
-45,380
-10,835
-1,120
-543
-920
Total Unusual Items
-45,380
-10,835
-1,120
-543
-920
Normalized EBITDA
-90,730
-78,391
-61,307
-77,908
-67,019
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-653.1295
-51.4978
-2.6471
-0.7829
-0.7264
12/31/2020 - 12/2/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

26CA.MU ImmunityBio Inc
3.1250
+7.39%
 
GBM.F Inovio Pharmaceuticals, Inc.
1.8800
+1.62%
 
OKUR OnKure Therapeutics, Inc.
4.8300
-4.73%
 
SLN Silence Therapeutics plc
4.3200
-4.00%
 
CNTA Centessa Pharmaceuticals plc
15.04
-3.28%
 
BCYC Bicycle Therapeutics plc
10.47
-4.56%
 
REPL Replimune Group, Inc.
12.12
-4.42%
 
INO Inovio Pharmaceuticals, Inc.
1.8400
-7.07%
 
IBRX ImmunityBio, Inc.
2.8500
-13.37%
 
VKTX Viking Therapeutics, Inc.
25.70
-10.98%